MindWalk Holdings (HYFT) EBT Margin (2020 - 2026)
MindWalk Holdings (HYFT) reported EBT Margin of 1.09% for Q1 2026, up 92341.0% year-over-year from N/an in Q1 2025, and up 100.0% quarter-over-quarter from 98301648884.58% in Q4 2025.
MindWalk Holdings (HYFT) EBT Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of EBT Margin data on file, last reported at 1.09% in Q1 2026.
- EBT Margin for Q1 2026 came in at 1.09%, up 92341.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 1.08% (up 20605.0% YoY), and the FY2025 annual result was 139751223.49%, down 13975110642.0% from the prior year.
- EBT Margin improved to 1.09% in Q1 2026 per HYFT's latest filing, from 98301648884.58% in the prior quarter.
- Over five years, EBT Margin peaked at 1.09% in Q1 2026 and troughed at 197250303275374.03% in Q3 2024.
- A 5-year average of 11608741743808.29% and a median of 88.57% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 2000000000 bps in 2024, then surged 2000000000 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 0.0% in 2022, then sank by 32568507 bps to 49.15% in 2023, then jumped by 91 bps to 4.44% in 2024, then plunged by 2000000000 bps to 98301648884.58% in 2025, then jumped by 100 bps to 1.09% in 2026.
- Business Quant data shows HYFT's EBT Margin at 1.09% in Q1 2026, 98301648884.58% in Q4 2025, and 154.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 1.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.09% |
| Oct 31, 2025 | -98,301,648,884.58% |
| Jul 31, 2025 | -154.32% |
| Apr 30, 2025 | -4,627,115.21% |
| Jan 31, 2025 | -922.32% |
| Oct 31, 2024 | -4.44% |
| Jul 31, 2024 | -197,250,303,275,374.03% |
| Apr 30, 2024 | -345.72% |
| Jan 31, 2024 | -53.27% |
| Oct 31, 2023 | -49.15% |
| Jul 31, 2023 | -71.18% |
| Apr 30, 2023 | -153.82% |
| Jan 31, 2023 | -88.57% |
| Oct 31, 2022 | 0.00% |
| Jul 31, 2022 | -0.22% |
| Apr 30, 2022 | -81.83% |
| Jan 31, 2022 | -91,443.41% |
| Oct 31, 2021 | -101.47% |
| Jul 31, 2021 | -1,797.43% |
| Apr 30, 2021 | -63.54% |